OTC Firms Question Enforceability Of Proposed USP Monograph Shake-Up
This article was originally published in The Tan Sheet
Executive Summary
OTC industry executives advise U.S. Pharmacopeia to proceed cautiously with novel approaches to modernizing its monographs, lest USP develop standards unenforceable by FDA.